# Switchpoint Bio **Source:** https://www.startuphub.ai/startups/switchpoint-bio **Profile type:** Startup > Developer of a blood-based epigenomic platform providing drug developers with insights into disease and treatment response. ## About Switchpoint Bio develops a blood-based epigenomic platform that profiles epigenomic marks from circulating immune cells to give drug developers a scalable view of how disease and treatment change human biology. By combining precision epigenomic profiling with AI, the platform enables biomarker discovery, patient stratification and treatment response monitoring for pharmaceutical R&D. ## Key facts - **Slug:** switchpoint-bio - **Website:** https://switchpointbio.com - **Location:** Helsinki, Finland - **Founded:** 2025-01-01 - **Employees:** 8 - **Operating status:** Active - **Total funding:** $5M - **Sectors / tags:** TechBio, Biotechnology, Epigenomics, HealthTech, Epigenetics - **Social:** - LinkedIn: https://www.linkedin.com/company/switchpointbio - Facebook: http://www.facebook.com/2008 ## StartupHub.ai scores - **Ahrefs DR:** 4/100 - **Agent Readiness:** D (53/100) - **Site Speed:** 53/100 - **Data Trust:** 72/100 ## Funding rounds | Date | Round | Amount | Lead investors | | --- | --- | --- | --- | | 1 Nov 2026 | [Pre-Seed](https://www.startuphub.ai/investment_rounds/switchpoint-bio-pre-seed-2026) | $5.3M | - | ## Tech stack Detected on switchpointbio.com, last scanned 2026-11-12. - **CMS / Builders:** Squarespace - **Email provider:** Google Workspace - **Hiring platform:** Teamtailor ## JSON-LD Structured data aligned with this page's `